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Non-alcoholic fatty liver disease (NAFLD) is an asymptomatic increasingly 
common disorder that affects liver metabolism and is often the precursor for liver 
pathologies such as fibrosis, cirrhosis and hepato-cellular carcinoma. The liver sinusoidal 
endothelial cells act as a liver sieve by allowing macromolecules and chylomicrons to 
traverse through their fenestrations (sieve plates) to hepatocytes. Since liver sinusoidal 
endothelial cells (LSEC) regulate serum derived macromolecular exposure to 
hepatocytes, we asked what role LSEC could play in the pathogenesis of NAFLD. To 
investigate the early events of NAFLD we used a rat model (Sprague-Dawley) in which 
animals were maintained on standard and high fat diets (HFD) for a period of 8 weeks.  
The lipid accumulation in the livers, isolated hepatocytes and LSEC were visualized by 
Oil Red O, BODIPY (boron-dipyrromethene) stains and CARS (Coherent Anti-stokes 
Raman Scattering) imaging. There was evidence of increased size of lipid droplets in the 
hepatocytes of HFD rats in contrast to their LSEC, which showed minimal to no lipid 
accumulation. The lipid content of the liver tissues was analyzed by thin layer 
chromatography, which revealed the accumulation of triglycerides and cholesteryl esters 
in the livers of HFD rats compared to the control rats. In vitro endocytosis of 
125
I-HA 
(hyaluronic acid) experiments carried out on LSECs isolated from the rat livers showed 
that the 
125
I-HA uptake is significantly higher in control rats compared to HFD rats. We 
also observed that serum HA levels and alkaline phosphatase (ALP) levels were 
increased in HFD rats, in contrast to alanine transaminase (ALT), triglycerides and 
cholesterol, which remained the same. Purified RNA from the isolated LSECs was 
subjected to microarray analysis demonstrating altered gene expression patterns between 
rats on two different diets. The kidneys, gut, and spleens were also harvested to study the 
interplay of the organs in the disease. We have been able to demonstrate that decreased 
endocytic ability of LSECs precedes fibrosis of liver in NAFLD. 
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Chapter 1 
Introduction and literature review 
1.1 Liver 
 The liver is the largest visceral organ in humans and other higher vertebrates 
contributing to about 2-5% of total body weight. It is a principal organ in the body as it 
maintains the internal homeostasis in the organism. The liver participates in synthesis, 
storage, export and secretion of various metabolites. Nutrients and other xenobiotics from 
the intestinal system are transported to the liver where they are metabolized. The liver 
clears various molecules and cells, foreign antigens and microbes from the blood stream. 
It has a wide variety of functions and is important for the maintenance of metabolic 
integrity of the body. The multiple functions of the mammalian liver are a combination of 
exocrine, endocrine and paracrine functions, carried out by specialized cell types listed 
below. All these varied functions take place in a unique structurally complex, 
multicellular tissue, called the liver (1).   
1.2 Cells of the liver 
 The liver consists of seven distinct types of cells - hepatocytes, cholangiocytes, 
sinusoidal endothelial cells, macrophages, lymphocytes, dendritic cells and stellate cells, 
arranged in a matrix, which allows them to work in co-ordination to synthesize, 
metabolize and clear a wide range of molecules. The cells of the liver are supplied with 
the various molecules by the flow of blood through a uniquely structured capillary 
system. The sources of blood to the liver are the venous and the arterial blood, which 
flow through the afferent and efferent blood vessels that interdigitate uniformly. This 
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vasculature is unique because it is separated by a parenchymal mass of cells and at the 
same time connected by small capillaries known as the sinusoids (1). 
1.2.1 Hepatocytes  
 The hepatocytes are referred to as parenchymal cells and all the other cells types 
are broadly termed non-parenchymal cells. The hepatocytes are large polyclonal cells, 
numerous in number, constitute about 60% of the cells and 80% of the volume of the 
liver. They are responsible for most of the metabolic and synthetic functions of the liver. 
The hepatocytes are complex rhomboid shaped and have distinct surfaces for the different 
functions they carry out. The area of the hepatocyte surface that faces the sinusoid is 
greatly amplified and shaped into folds known as microvilli, which extend into the space 
of Disse. Adjacent hepatocytes are held together to form long cords of cells by 
intercellular adhesion complexes. The intercellular membrane has gap junctions for 
transport of small molecules between adjacent cells. The intercellular membrane is 
mostly flat, except at regions where it forms bile canaliculi. The bile canalicular 
membrane is modified for the secretion of bile. The membrane facing the sinusoidal 
lumen performs extraction of a wide variety of molecules from the blood and 
simultaneous secretion of molecules synthesized by the hepatocytes (2). The non-
parenchymal cells include stellate cells (HSC), Kupffer cells (KC) and liver sinusoidal 
endothelial cells (LSEC).  
1.2.2 Macrophages or Kupffer cells (KC) 
  These cells occupy about 2% of the liver. They are located within the sinusoidal 
lumen, held closer to the LSEC by loose attachments. The KC express C3 and Fc 
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receptors which clear large particulate material such as bacteria, worn out cells, dead 
hepatocytes by phagocytosis. The KCs also clear immune complexes, tumor cells, 
liposomes, lipid microspheres, iron and various other particulate matter. Clearance of 
circulating endotoxin is one of the most important functions of  KCs. Endotoxins activate 
KCs and result in the secretion of interleukin-1/1 and tumor necrosis factor, reactive 
oxygen species, and transforming growth factor-β (3-5).  
1.2.3 Stellate cells (HSC) 
 The stellate cells (HSC) are located in the space of Disse between the hepatocytes 
and the sinusoids and comprise 1.5% of the liver. Stellate cells store retinoids, 
triglycerides, cholesterol and free fatty acids. HSC also secrete and degrade components 
of the peri-sinusoidal matrix. During liver injury, these cells respond to inflammatory 
cytokines such as IL-6 and TGF-β, become activated and acquire a myofibroblastic stage. 
They undergo morphological changes, start proliferating and become contractile, lose 
their lipid stores and secrete fibrogenic and inflammatory cytokines, which if left 
unchecked, lead to fibrosis (6). 
1.2.4 Sinusoidal endothelial cells (LSEC) 
  The liver sinusoidal endothelial cells (LSECs) comprise about 3% of the liver. 
These cells are flattened and comprised of holes or fenestrations that are grouped together 
to form sieve plates. The sinusoidal endothelium lacks a basement membrane, which 
makes it unique from all other endothelial cells. LSECs are responsible for the clearance 
of various molecules in the blood that flows through the sinusoids. They are also essential 
components of the liver centered innate immune system, which also includes Kupffer 
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cells, lymphocytes and dendritic cells (1). Since LSEC are the main focus of our study, 
the functional aspects of this cell type are discussed in detail in the subsequent sections. 
1.2.5 Cholangiocytes 
 The cholangiocytes are cells that line the bile ducts and form 1% of the liver 
parenchyma. These cells are responsible for the modification of the canalicular bile 
composition, which occurs through a series of secretory and absorptive processes (7, 8). 
Cholangiocytes also interact with other liver cells such as hepatocytes, LSEC, HSC and 
KC by releasing growth factors, peptides, nucleotides, pro-inflammatory and chemotactic 
cytokines and other signaling molecules (7). These cells are involved in regulation of bile 
formation, liver inflammatory processes, angiogenesis and fibrogenesis because of their 
interaction with the other liver cells (8). 
1.3 Organization of the liver  
 Hepatocytes are arranged in the form of cords through tight junctions that keep 
them together. Vascular sinusoids are present on either side of the hepatocytes. The space 
between the sinusoidal endothelium and hepatocytes is known as space of Disse. Stellate 
cells are present in the space of Disse. The KCs are present in the sinusoidal lumen and 
are loosely attached to the endothelial cells. The sinusoidal endothelium, because of its 
position, is in interaction with all other cells of the liver and plays a crucial role in the 
supply of required material to the hepatocytes and also in the scavenger and immune 
systems of the liver (Fig. 1). Hepatocytes and other cells communicate by extending their 
pseudopodia and microvilli through the fenestrations of the LSECs (Fig 2). Fenestrations 
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permit the passive transport of solutes and regulate the traffic between blood and the 
underlying hepatocytes (9). 
         
Figure 1: Basic architecture of the liver. LSEC form the walls of the sinusoids and are 
fenestrated. Stellate cells are found in the space of disse, whereas the Kuppfer cells are 
found in the sinusoidal lumen. The lumen is lined on both sides by hepatocytes. 
1.4 Structural and functional aspects of sinusoidal endothelial cells  
 Sinusoidal endothelial cells constitute the second most abundant cell type in the 
liver. They are present between the hepatocytes and blood. The presence of sinusoidal 
endothelial cells as a unique cell type was not discovered until the perfusion fixation and 
electron microscopy studies by Wisse et al (10). Although LSEC populations contribute 
to only 6.3% of the total liver volume, they represent approximately 40% of the total 
number of hepatic cells (11). 
1.4.1 Sieve function of the LSEC   
 LSEC have a unique morphological phenotype called the fenestrated endothelium. 
The fenestrated endothelium is a subset of discontinuous endothelium, where the cells 
have pores traversing the cytoplasm. Each pore is approximately 100 to 150 nm in 
diameter. Macromolecules larger than 100nm-120nm in diameter or rigid molecules are 
not allowed to diffuse through the fenestrae, attributing a sieve function to LSEC (12).  In 
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addition to the fenestrated endothelium, the cells also lack an organized basement 
membrane. The paracrine secretions of the adjacent cells maintain the unique structure of 
the endothelium. Hepatocytes and HSC secrete vascular endothelial growth factor 
(VEGF), which stimulates LSEC to constitutively produce nitric oxide (NO) by 
endogenous nitric oxide synthase (eNOS) (13). The LSEC maintains fenestrations for a 
longer duration when exogenous VEGF is provided to the cell culture and VEGF induces 
endothelial fenestrations in vitro (14).   
                 
 Fig 2: Electron micrograph of sinusoidal endothelial cells, displaying the presence of 
fenestrae clustered into sieve plates. The encircled region indicates a sieve plate and the 
arrows point towards microvilli extending through the fenestrations. 
  LSECs lose their fenestrations in a process called capillarization or de-
fenestration due to the formation and deposition of extracellular matrix and build up in 
the space of Disse resulting in LSEC dysfunction. Deposition of collagen and laminin, 
and thickening of the LSEC, characterizes defenestration (14). Defenestration precedes 
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fibrosis and has been observed in various disease conditions such as primary biliary 
cirrhosis (15), hepatitis (16), specific viral infection of the LSEC (17) and with the 
venous administration of endotoxin (12, 18).  
1.4.2 Functions of sinusoidal morphology 
 The LSEC fenestration allows chylomicrons and VLDL remnants to pass through 
the sieve and allows access to the hepatocytes. Blood flow to the liver is a combination of 
both arterial and venous blood. Normal arterial pO2 is 90-100 mm Hg and the pO2 for 
portal vein is 45-55 mm Hg. As a result, tissue oxygenation of the liver is lower than that 
for the other tissues (1). The presence of fenestrae optimizes the delivery of oxygen to the 
hepatocyte.  There are various studies that explore the role of fenestrae in various 
conditions, such as liposomal transport (19), hydrodynamics (20), liver regeneration (21), 
the role of VEGF regarding porosity (22), nitric oxide synthesis (23) and old age (24). 
The fenestrae are important for the process of drug clearance. It allows the passage of 
bound and unbound drugs to the space of Disse for uptake and clearance by the 
hepatocytes (12).    
1.4.3 Scavenger functions 
 The LSEC are the primary scavenger system of the liver. They contain numerous 
coated pits on their surface which creates a cationic surface charge that allows for 
endocytosis of negatively charged molecules. Different types of scavenger receptors such 
as hyaluronan receptors, mannose macrophage receptors and Fc gamma receptors are 
expressed by LSECs, which allow the removal of various macromolecules from the blood 
such as proteins, polysaccharides, lipids and nucleic acids (25). The LSECs internalize 
macromolecular waste such as extracellular matrix breakdown products (26), lysosomal 
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enzymes (27), immune complexes (28), advanced glycation end products (29), acetylated 
and oxidized low density lipoproteins (30)and modified proteins (31). There are recent 
studies that suggest that LSECs might be involved in viral clearance  
1.4.4 Stabilin receptors  
 This class of Type I multi-domain transmembrane receptors consists of two 
proteins, Stabilin-1 and Stabilin-2. Stabilin-1 is expressed by LSECs in liver, spleen, 
lymph nodes and alternatively activated macrophages (32).They both consist of multiple 
EGF-like and fasciclin domains and a single X-link domain with amino acid sequences 
that are 55% identical and 42% similar (Fig 3). The X-Link domain in Stabilin-1 is non-
functional in that it does not bind hyaluronan. Stabilin-1 and Stabilin-2 have both 
common and different ligand binding profiles. Stabilin-1 mediates endocytosis of 
acetylated LDL (33), SPARC (Secreted protein acidic and rich in cysteine) (34), 
Advanced glycation end products (AGE)(29), placental lactogen (35) and 
phosphatidylserine (36, 37). Stabilin-1 functions as a bacteria-binding protein and 
modulates angiogenesis (38). It helps in the lymphocyte migration and entry of 
leukocytes to the site of inflammation (39). 
 Hyaluronic acid (HA) is a matrix polysaccharide with repeated disaccharide units 
of D-glucuronic acid and N-acetyl glucosamine. HA is a major constituent of the ECM, 
and serum HA is known to be associated with inflammation, wound healing, and 
regenerative morphogenesis. Elimination of denatured or excess HA from the circulation 
is necessary to maintain the normal range of blood viscosity (40). Stabilin-2 is 
responsible for the efficient uptake of hyaluronic acid and degradation and functions to 
regulate the amount of HA present in the body (26). In addition,  Stabilin-2 receptors 
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eliminate oxidized LDL and acetylated LDL (41), advanced glycation end products (29), 
N terminal propeptides of types I and III procollagen (PINP and PIIINP) (31, 36), 
phosphatidylserine(42) , chondroitin sulfates(43), and high and low molecular weight 
heparins(44, 45) and small heparin oligos(46). In both rat and human, two isoforms of 
HARE are present with molecular masses of 175 and 300 kDA or 190 and 315 kDa, 
respectively. The isoforms are derived from the same precursor, which is the Stabilin-2 
protein. Stabilin-2 is a large protein consisting of 2551 amino acids. The full length 
315/300 kDa isoform is a type I membrane protein that contains a 2458 extracellular 
domain which contains four cysteine rich/fasciclin like domains and a LINK domain 
which binds to hyaluronic acid. The 190 kDa is similar to the C-terminal 1417 amino 
acids of the 315 kDa and is derived by proteolytic cleavage by unknown mechanisms 
(47). The clearance of HA by Stabilin-2 receptor has been used as a marker to determine 
overall health of the liver (48, 49). 
  
Fig 3: Stabilin receptors of the sinusoidal endothelial cells (36). 
 The mannose receptor is identical to the macrophage mannose receptor of the 
Kupffer cells. It is responsible for the removal of waste collagen molecules and 
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breakdown products that are degraded in the body by collagenolysis. This receptor 
prevents the accumulation of gelatin, preventing conditions such as intravascular clotting. 
These receptors facilitate calcium dependent clearance of glycoconjugates, which have 
mannose residues at their terminus. The mannose receptor is involved in the uptake of the 
lysosomal enzymes, tissue plasminogen activator and the carboxy-terminal properties of 
type I procollagen (50). The Fc gamma receptor of the LSEC is similar to the receptors 
on Kupffer cells. These receptors are involved in the receptor-mediated endocytosis of 
immune complexes (51, 52).  
1.4.5 Secretory functions 
 The release of prostanoids from KC and LSEC following exposure to endotoxin 
triggers glycogenolysis in hepatocytes (53). The release of nitric oxide (NO) from LSEC 
potentiates calcium signaling in surrounding hepatocytes (23). LSEC synthesize and 
secrete fibronectin (54)  and secretes endothelin, a potent vasoconstrictor, on exposure to 
endotoxin treated Kupffer cells (55).               
1.4.6 Sinusoidal dysfunction 
 The sinusoidal endothelial function is affected in various pathological conditions. 
The fibrosis of liver is preceded by capillarization of the sinusoidal endothelium (56). 
Capillarization promotes fibrosis as the capillarized LSECs activate the hepatic stellate 
cells, which play an important role in the development of fibrotic liver (57). The 
capillarization of LSEC also affects the delivery of oxygen to the hepatocytes and causes 
hepatocyte hypoxia. The clearance of chylomicron remnants is affected by the size of 
LSEC fenestrae. The normal function of the fenestrae prevents atherosclerosis due to 
proper clearance of chylomicrons (58). Loss of endothelial fenestrae in liver cirrhosis 
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may contribute to loss of hepatic function because of impaired exchange between 
sinusoidal blood and hepatocytes. In aging animals, a process known as psuedo-
capillarization is observed with the thickening of the LSEC, marked reduction in size and 
number of fenestrae and an incompletely formed basement membrane (59). In response 
to injury, LSEC increase their production of cellular fibronectin (60).               
1.5 Non-Alcoholic Fatty liver disease (NAFLD) 
 NAFLD is one of the rising health concerns in both the developing and developed 
countries. It includes a spectrum of diseases ranging from simple infiltration of fat into 
the liver tissues (steatosis) to cirrhosis and cancer. NAFLD is considered the hepatic 
manifestation of metabolic syndrome, which includes type 2 diabetes mellitus, 
hyperlipidemia, obesity and insulin resistance. The pathology of NAFLD is not clear. 
Obesity and insulin resistance pose a high risk for development of NAFLD (61). NAFLD 
begins as a simple deposition of fat in the hepatocytes. The accumulation of fat occurs 
due to various early mechanisms. These include excessive intake of calories composed of 
a variety of fats and carbohydrates, coupled with obesity (62), and excessive consumption 
of high fructose foods/drinks, resulting in impaired lipid metabolism (63). There is an 
increase in the export of fatty acids from adipose tissue and intestine to the liver. As the 
amount of fatty acids imported by the liver is higher than the amount needed by it, the 
excess results in an accumulation of triglycerides in the liver. Hyperinsulinemia causes 
increased fat storage by the liver. Insulin resistance results in increased triglyceride 
synthesis, fatty acid uptake and peripheral lipolysis resulting in fat accumulation in the 
liver (64, 65). Uncontrolled steatosis coupled with the other risk factors proceeds to 
fibrosis of the liver. In fibrotic conditions, the stellate cells are activated and attain a 
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myofibroblastic stage. They secrete cytokines and extracellular matrix, resulting in the 
augmentation of fibrosis. The fenestrae of the sinusoidal endothelium are lost and the 
development of basement membrane occurs, resulting in capillarization of the sinusoidal 
endothelium. The hepatocytes lose their microvilli and proceed to apoptosis. The Kupffer 
cells are activated and secrete inflammatory cytokines (Fig 4). Sinusoidal endothelial 
cells are known to maintain stellate cells in their dormant stage (66). Recent studies show 
that LSEC dysfunction precedes inflammation and fibrosis in NAFLD (67), suggesting 
that the LSEC might be responsible in initiating the fibrotic conditions. In NAFLD, 
capillarization of sinusoidal endothelium has been observed (68)  and serum HA levels 
were found to be elevated (69). There is no known direct correlation between sinusoidal 
dysfunction and NAFLD, which forms the focus of this study.                
 
Fig 4: Cells in liver fibrosis and injury (70).  
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Chapter 2  
Isolation of liver sinusoidal endothelial cells  
2.1 Introduction 
 The liver is the metabolic center of the mammalian body and serves as a filter for 
the blood. The basic architecture of the liver is majorly composed of hepatocytes (~ 80 
%) and the remaining of the cellular mass is composed of Kupffer cells (KCs), stellate 
cells (HSCs), and sinusoidal endothelial cells (LSECs). LSECs form the blood vessel 
walls within the liver and contain specialized morphology called fenestrae. Fenestration 
of the cytoplasm is the appearance of holes (~100 μm) within the cells so that the LSECs 
act as a sieve in which most macromolecules, but not cells pass through to the 
hepatocytes and HSCs. Due to the lack of a basement membrane, the gap between the 
LSEC and hepatocytes form the space of Disse (71). HSCs occupy this space and play a 
prominent role in regulation and response to injury, storage of retinoic acid and immuno-
regulation of the liver (72). LSEC are among the most endocytically active cells of the 
body displaying an array of scavenger receptors on their cell surface. These include SR-
A, Stabilin-1 and Stabilin-2. Generally, small colloidal particles less than 230 nm and 
macromolecules in buffer phase are taken up by LSEC, whereas large particles and 
cellular debris are endocytosed (phagocytosed) by KCs (73). Thus, the bulk clearance of 
extracellular material such as the glycosaminoglycans from blood is largely dependent on 
the health and endocytic functions of LSEC.  An increase in blood hyaluronan levels is 
indicative of liver disease ranging from mild to more severe forms (74). 
 LSEC de-differentiate under standard culture conditions and must be used within 
1 or 2 days upon isolation from the animal. With the exception of one report (75), there 
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are no immortalized LSEC cell lines in existence. Even this immortalized cell line is de-
differentiated in that it does not express scavenger receptors that are present on primary 
LSEC (our data, not shown). All cell biological studies must be performed on primary 
cells obtained freshly from the animal. Differentiation of LSEC is marked by the 
decreased expression of Stabilin-2 or HARE receptor, CD31, and the presence of 
cytoplasmic fenestration (47). Differentiation of LSEC can be extended by the addition of 
VEGF (76) in culture media or by culturing cells in hepatocyte conditioned medium (77). 
The following protocol is adopted from (78, 79)   with modifications (45, 80).  
2.2 Materials and methods 
2.2.1 Excision of liver 
  10 mL of 30% isoflourane in polyethylene glycol was added to a petri dish in a 
closed 5.5 L chamber and allowed to equilibrate within the chamber. The rat was 
anesthetized by placing it in the sealed chamber. Some cotton balls were put in a 30 mL 
syringe tube and 2 mL of 30% isoflourane was added to it. The anesthetized rat was 
placed on its back on a diaper-covered tray and the syringe tube was placed over the 
snout. The entire abdominal cavity was exposed using bandage scissors and forceps. Two 
strands of surgical silk or polyester thread (ligature) were drawn beneath the vena porta 
immediately above the mesenteric branch using forceps. The forceps was withdrawn and 
a loose overhand knot was tied. The vena porta was cannulated with an Insyte autoguard 
catheter (18 GA, 1.3 x 300 mm, BD Biosciences). The needle was retracted by releasing 
the spring-loaded trigger on the catheter. The overhand knot was tightened and secured 
with another knot. The descending aorta (aorta abdominalis) was severed to allow blood 
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to drain from the circulatory system. The liver was flushed with oxygenated tris buffered 
saline (TBS, 154 mM NaCl, 10 mM trizma base salt, pH 7.4 ) at 37°C to remove the 
blood at a flow rate of 20 mL/min. The liver turned from reddish purple to a loam color. 
The liver was excised while being flushed by cutting away the GI tract and connective 
tissue. The liver was placed on a plastic net over a funnel that allows buffers to be 
collected and re-circulated and flushed for 10 min. The schematic of the perfusion 
apparatus is illustrated in Fig 5. 
2.2.2 Digestion of the liver by collagenase digestion 
 Freshly dissolved and filtered (0.45 μm) collagenase (100 mg/kg rat weight) was 
added to 60 mL of Perfusion buffer 2 (67 mM NaCl, 6.7mM KCl, 4.8mM CaCl2.H2O, 10 
mM HEPES,15% BSA, pH 7.4). The pump was stopped and the inlet tubing was 
exchanged from the TBS flask to the collagenase solution. Immediately after flushing, the 
digestion with collagenase was begun in a circulatory loop at a flow rate of 20 mL/min, 
for up to 15 min. After flushing with collagenase, the pump was stopped, the catheter  
was removed and the liver was transferred to a dish containing 20-30 mL of perfusion 
buffer 1(142 mM NaCl, 6.7mM KCl, 10mM HEPES, 1.5% BSA, pH 7.4). The Glisson’s 
capsule was peeled from the liver and the cells were shaken out in the liquid. As the 
liquid becomes opaque with cellular material, the cells were transferred through a 100 μm 
mesh, followed by filtration through a 30 μm mesh and then into a 50 mL conical tube on 
ice. More Buffer 1 was added to the liver and cells were shaken from the liver matrix, 
transferring the liquid to the mesh filters and conical tube. The above steps were repeated 
until no more cells can be dislodged with reasonable shaking of the liver. 
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Fig 5: Schematic of the perfusion apparatus. A) Set-up of apparatus during the 
flushing/washing of the sinusoids of the liver, TBS is in a 1 L flask. B) A 125 mL flask 
containing ~60 mL Buffer 2 with collagenase is used for digestion of the liver in a closed 
circuit. The effluent line is also changed from the waste container to flask B through a 
notch cut in the rubber stopper. The oxygen line is not submerged into the buffer 
containing collagenase (flask B) to avoid foaming. The stoppers on each flask are 
notched to allow efficient transfer of the effluent line and to prevent increased pressure 
from the oxygen gas. 
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2.2.3 Hepatocyte and LSEC purification 
   The 50 mL conical tubes containing cells were centrifuged at 150 x g for 3 min to 
pellet the hepatocytes. The liquid fraction containing non-parenchymal cells was 
transferred to fresh 50 mL conical tubes on ice. The hepatocytes were washed by re-
suspending the pellet in perfusion buffer 3 (137mM NaCl,4.7mM KCl,0.7mM 
MgSO4,1.2mM CaCl2.2H2O,10mM  HEPES,1.5% BSA, pH 7.4) and the washes were 
repeated two more times. At the end of the washes, the pellets were ≥97% pure 
hepatocytes. The LSEC were obtained by centrifuging all of the tubes containing the 
pooled supernatant (containing HSCs, LSEC, and KCs and some small hepatocytes) at 
200x g for 10 min at 4°C. The buffer was aspirated and all the pellets were re-suspended 
in a total of 35 mL RPMI/BSA (15g/L BSA in RPMI) at 4°C and centrifuged at 100 x g 
for 3 min. The top 25 mL of liquid was collected and transferred to a clean 50 mL conical 
tube. The pellet was re-suspended in the remaining 10 mL media and 25 mL of cold 
RPMI/BSA was added and centrifuged at 100 x g for 3 min. The above steps were 
repeated, and the cell pellet was discarded along with 10ml media. The supernatants were 
centrifuged to pellet LSECs, KCs, and HSCs at 200 x g for 10 min at 4°C. Meanwhile, 
percoll gradients were prepared by adding 20 mL 25% percoll in PBS on ice and then 
underlaying with 15 mL 50% percoll in each tube.  
 The cell pellets were re-suspended in a total volume of 30 mL RPMI/BSA. Each 
gradient was carefully overlaid with 10 mL of cells and centrifuged at 900 x g for 20 min 
at 4°C. LSECs and KCs have very close buoyant densities and collect at the 25/50% 
interface. HSCs are typically at the 25%/media interface due to their higher buoyancy as 
lipid storing cells. Any remaining hepatocytes and blood cells have the lower buoyancies 
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and are pelleted. The media and stellate cells were aspirated from the top down near the 
25/50% interface and the cells in the 25/50% interface were collected and transferred to a 
fresh conical tube with cold RPMI. The final volume was adjusted to ~40 mL to dilute 
out the percoll. The conical tube was centrifuged at 350 x g for 10 min at 4°C to pellet 
the cells. The cells were resuspended in ~10 mL pre-warmed RPMI at 37
0
 C containing 
100 U/mL penicillin, 100 µg/mL streptomycin and the cells were placed in an acid-
washed glass-crystallizing dish. The cells were incubated for 15 min at 37°C in a tissue 
culture incubator. The LSECs in the supernatant were collected from the dish by rocking. 
The KCs adhere to the glass much more rapidly than LSECs. Alternatively, LSECs may 
be separated from KCs by immunopurification using anti-CD31 or anti-Stabilin2/HARE 
antibodies conjugated to magnetic beads. Viability and cell numbers were assessed by 
trypan blue exclusion using a hemacytometer or with using an automated cell counter. 
The LSECs were cultured on fibronectin-coated plastic dishes (Fig 6) at 37°C, 5% CO2, 
RPMI/0.25% BSA with 40 ng/mL VEGF, 100 U/mL penicillin, 100 μg /mL streptomycin 
or with hepatocyte conditioned media. The LSECs was assessed for internalization of 
I
125
-HA. 
2.3 Discussion 
 Anesthesia of the rat by the hanging drop method in which isoflourane vapor 
induces unconsciousness is the preferred method for our studies. A vaporizer may also be 
used instead of a syringe with cotton to maintain the animal outside the chamber, but the 
surgical procedures are so quick, it is not required. Polyethylene glycol is added to the 
isoflurane to decrease the vapor pressure and evaporation rate. Too much isoflurane 
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vapor will induce death too quickly. If the animal dies before the liver is cannulated and 
blanched with TBS, pooling blood may clot in the liver and prevent efficient washing of 
the sinusoids and digestion with collagenase. Gey's buffered saline solution (GBSS) is 
often substituted by other laboratories for the purification of LSECs. While it is useful for 
LSEC purification, hepatocytes do not tolerate GBSS as well as Buffers 1-3 and 
viabilities are not nearly as high. When measuring endocytosis, it is good practice to 
measure background levels in the organ and in purified hepatocytes. This method is one 
of two for efficient purification of LSECs following the liver perfusion with collagenase.  
 The other method separates the non-parenchymal cells by elutriation 
centrifugation (81), instead of percoll gradient. The advantages for using elutriation over 
percoll gradients are slightly higher cell viabilities and numbers. The downside is that 
elutriation centrifugation requires a specialized rotor, dedicated centrifuge, and peristaltic 
pump together which costs tens of thousands of dollars. This method only requires the 
use of a refrigerated table-top centrifuge and peristaltic pump which is standard in many 
laboratories. Separation of LSECs and KCs by selective adhesion is a standard method 
(82, 83). While it is true that SECs will adhere to the glass and plastic, the key point is to 
use acid-washed clean glass with no more than 15-minute incubation at 37°C at 5% CO2. 
KCs will always adhere faster than LSECs and it is advisable to gently wash the KCs 
with media to extract any remaining LSECs that have become loosely attached. Pronase 
and other proteases are also omitted from the collagenase digestion steps in this protocol 
to increase viabilities of the cells. Proteases digest extracellular receptors and may inhibit 
cellular adhesion in the final purification steps. The method presented here has a wide 
variety of applications. Perfusion of the liver for obtaining primary hepatocytes, KC, 
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LSECs, and HSCs may be useful for a number of studies involving metabolic pathways, 
immunoregulation, scavenger activities, and other physiological studies. The most 
difficult part of this procedure is good cannulation, digestion of the liver, and handling of 
the liver without having the catheter slip from the portal vein. 
 
                         
Fig 6: LSECs plated on fibronectin coated plastic 6-well dishes were incubated overnight 
in RPMI supplemented with 0.1% BSA. Phase contrast images were taken at 100x 
magnification. 
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Chapter 3  
Effect of high fat diet on the liver 
 
3.1 Introduction 
 The liver is central to the maintenance of energy balance as it regulates the supply 
of glucose, ketone bodies, lipoprotein and triglycerides to peripheral tissues. Thus, it acts 
as the primary processing center for the dietary derived lipids and glucose. The liver 
stores excess glucose as glycogen and excess dietary-fatty acids and excess adipose 
tissue-derived fatty acids in the form of triglycerides. In conditions of fasting or energy 
insufficiency, the liver increases synthesis of very low-density lipoproteins (VLDL), β-
oxidation of fatty acids and ketogenesis. As the liver plays an important role in proper 
metabolic handling of fatty acids, impairment of fatty acid storage in the liver due to 
increased lipid intake poses as an important factor for the development of the metabolic 
syndrome which includes insulin resistance, Type 2 diabetes, non-alcoholic fatty liver 
disease (NAFLD), and cardiovascular disorders (84).  
 It has been observed that serum triglycerides, liver enzymes serum alanine 
transaminase and alkaline phosphatase, cholesterol, serum HA are increased in NAFLD 
(85). Fibrosis begins to develop in the liver due to high fat diet ingestion and NAFLD 
(86). The following experiments were performed to evaluate the condition of the liver 
and observe if fat accumulation has occurred and if fibrosis has initiated, in the livers of 
the rats fed on high fat diet. Whole tissues were stained with H&E, Oil Red O and subject 
to Coherent Anti-stokes Raman Scattering (CARS) microscopy. H& E is a combination 
of two dyes, haematoxylin and eosin. Haematoxylin stains the acidic parts of the cell like 
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the nucleus and nuclear material, whereas, eosin stains the basic components of the cell 
such as proteins. This staining technique helps to visualize the morphology of the tissues. 
Oil Red O is used to detect neutral lipids in the tissues. The staining is based on the 
capability of the lipids to dissolve in the dye (87). CARS is a technique used to visualize 
the lipids in tissues or individual cells. It is a label free imaging technique which is highly 
sensitive and capable of visualizing lipid rich structures. CARS microscopy relies on the 
intrinsic molecular vibration for contrast mechanism.  It is particularly sensitive to the 
lipid-rich structures due to the abundance of the CH 2 group and the distinctive CH 2 
stretch-vibration frequency at 2840 cm
- 1
 (88).  
3.2 Materials and methods 
3.2.1Sample collection 
  Four week old Sprague-Dawley rats were maintained on standard diet (12% 
energy from fat) or high fat diet (60% energy from fat) for 8 weeks. The diet was 
manufactured by Testdiet and the composition of the diets is given in table 1. The weight 
of the rats was measured every week. On the completion of the 8th week, the rats were 
sacrificed and tissues harvested. The rats were fasted for 2 hours prior to sacrifice. The 
cells of the liver were separated by the perfusion technique described in chapter 2. Blood 
was collected from the aorta abdominalis during the surgical procedure. Plasma was 
collected from blood and was stored at -80
0  
C for later analyses. Liver, kidney, spleen, fat 
pads tissues were stored at -20
0
 C after adding RNAlater RNA stabilization reagent 
(Qiagen) for future use.  
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3.2.2 Biotinylation of advanced glycation end products (AGE) 
 Advanced glycated end-products (AGE) are the lipids or proteins that have been 
glycated due to prolonged exposure to sugars (89). The AGE products in the serum are 
biotinylated to prevent the reduction of these molecules and enable storage for longer 
duration. 300 µL of plasma was immediately mixed with 300 µL of 10 mM biotin 
hydrazide to a final concentration of 5 mM biotin hydrazide and the mixture was allowed 
to react for 2 h at room temperature. After addition to the sample of an equal volume of 
30 mM sodium cyanoborohydride in PBS, the mixture was stored in an ice bath for 45 
min for promoting the reduction of the Schiff base formed in the hydrazide reaction. The 
mixture was subjected to dialysis against PBS, to remove excess reagents (90). The 
advanced glycation end products were collected for mass spectrometric analysis. 
3.2.3 Histology of the liver 
  The liver tissues were fixed in 10% PBS-buffered formalin and subject to two 
staining procedures: H&E staining and Oil Red O performed at the Veterinary Diagnostic 
Center, UNL.   
3.2.4 Blood chemistry 
 The liver profile was measured using Vetscan chemistry analyzer (Abaxis). The 
VetScan Mammalian Liver Profile reagent rotor used with the VetScan Chemistry 
Analyzer utilizes dry and liquid reagents to provide veterinary in vitro quantitative 
determinations of alanine aminotransferase (ALT), albumin (ALB), alkaline phosphatase 
(ALP), bile acids (BA), total bilirubin (TBIL), total cholesterol (CHOL), gamma 
glutamyl transferase (GGT), and (blood) urea nitrogen (BUN) in heparinized whole 
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blood, heparinized plasma, or serum (Abaxis vetscan protocol). Heparinized whole blood 
was used for the analysis. Triglyceride levels in the serum were measured using a 
triglyceride assay kit (Cayman Chemical) according to the manufacturer's instructions. 
Free fatty acids were measured using Bioassay systems Enzychrom free fatty acid assay 
kit. 
3.2.5 Thin layer chromatography of lipids  
 Liver tissues of control and HFD rats were frozen at -80
0
 C immediately after 
excision. They were thawed on ice on the day of the experiment for use. Fifty mg of liver 
tissue was weighed and used for lipid extraction. The tissue was homogenized in 3 mL of 
chloroform: methanol (2:1) solution containing 0.05% BHT (butylated hydroxy toluene). 
The homogenate was transferred to a glass tube and shaken at room temperature for 1 hr. 
Then it was centrifuged at 2500 rpm for 10 min. The supernatant was collected and 2 mL 
of 0.9% KCl was added and mixed well by vortexing. It was set aside for ~ 20 min until a 
phase separation was seen. The upper phase was carefully aspirated. The lower phase was 
transferred to another tube and centrifuged for 5 min at 2000 rpm. The pellet was 
obtained and resuspended in chloroform. The sample tubes were sealed under argon gas 
for longer storage periods to avoid lipid peroxidation. The samples along with 
triglyceride and cholesteryl ester standards were loaded on K5 20 X 20 TLC plates using 
a TLC spotter. The solvent system used was Hexane: Ether: Acetic acid (8:2:0.1). The 
bands were developed by placing the TLC plate in iodine vapor saturated container. The 
intensity of the bands was measured using densitometry by ImageJ. 
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3.3 Results 
  The weight gain of the HFD rats and control rats over the period of 8 weeks and 
was not significantly different (Fig 7). The visual examination of the livers from the 
control and HFD rats revealed a distinct morphological difference. The livers of the HFD 
rats look mottled and yellowish in color compared to the control (Fig 8). The livers of the 
HFD rats show increased lipid accumulation compared to the livers of the control rats, as 
evidenced by the H& E staining and Oil Red O staining (Fig 9). Huge lipid droplets were 
observed in the livers of HFD rats compared to the control rats, by CARS imaging (Fig 
9). 
 Though there are various studies that indicate that there is an increase in serum 
triglyceride and serum cholesterol in NAFLD (91), our experiments showed that the 
serum triglyceride, serum cholesterol of the HFD rats were not significantly different 
from the control rats (Fig 10) suggesting transport systems for fatty acids is not impaired. 
We observed an increase in serum alkaline phosphatase levels in the HFD rats, whereas 
the levels of serum ALT were not significantly different (Fig 11). Though a significant 
difference in serum triglyceride was not observed, thin layer chromatography of the lipids 
isolated from the livers of the control and HFD rats reveals that there is an accumulation 
of triglyceride and cholesteryl ester in the livers of the HFD rats (Fig 13). Densitometry 
measurements show a statistically significant difference in the accumulation of 
triglycerides and cholesteryl ester in the HFD livers compared to the control (Fig 14). 
The serum of the HFD rats shows an increased free fatty acid content (Fig 12), though the 
difference is not statistically significant due to low sampling number (n=4). 
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3.4 Discussion 
 The ingestion of high fat food by the rats for a period of 8 weeks has resulted in 
significant changes in their livers compared with the rats maintained on control diet. The 
liver shows significant damage and is in the initial stages of fibrosis. They show an 
increased accumulation of lipid, especially triglycerides and cholesteryl ester. Though 
there is no significant change in liver enzyme, ALT, serum triglyceride and serum 
cholesterol values, there is a significant increase in serum ALP, which is indication of 
liver damage and injury. An increase of serum free fatty acid could be observed in the 
HFD rats, which indicates the increased lipolysis observed in insulin resistance. All these 
experiments show that this diet was a successful model for initiating lipid accumulation 
and resulting in NAFLD in the rats. 
  Though there are various studies about the increase of serum triglycerides, 
cholesterol and aminotrasferases in non-alcoholic fatty liver disease (61, 84). The levels 
of serum alkaline phosphatase alone is elevated in our observations. It is concurrent with 
observations of another study where only the elevation of serum alkaline phosphatase 
levels are observed (92). Alkaline phosphatase levels are generally increased in 
conditions of biliary obstruction (93). The relation between sinusoidal endothelial 
dysfunction and biliary obstruction is an interesting aspect to investigate. 
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Table 1: Composition of standard diet. 
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Table 2: Composition of high fat diet 
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Fig 7: Weight: Four week old Sprague-Dawley rats were fed either control (black bars) or 
high fat (red bars) diets. Weight gain was measured weekly. n= 10 
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Table 3: Blood chemistry  
 
 
 
 
 
 
 
 
 
 
Parameter Control High fat  P value 
Weight (gms) 320 ± 6.899  354 ± 8.5 0.005 
Albumin (g/dL) 4.3 ± 0.118 4 ± 0.0886 0.032 
ALP (U/L) 167± 18 358 ± 25 ≤ 0.001 
ALT (U/L) 36 ± 2.3 40 ± 1.7 0.226 
BUN (mg/dL) 15±0.7 16±0.9 0.474 
Serum cholesterol(mg/dL) 95.6±7.7 112 ±4.3 0.073 
Serum 
triglyceride(mg/dL) 
91.2±11.8 67.1± 7.6 0.103 
Serum HA 27.3±3.4 41.5±4.5 0.02 
Serum bile acids (umol/L) 14.6 ± 4.9 13.2±2.7 0.793 
Food consumed (Kcal) 50,712  57,440  
Serum free fatty acids 
(µmol/L) 
153.75± 22.8 229±44 0.182 
n = 4 
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   Fig. 8:  Abdominal exposure and visual inspection of livers of rats fed (A) control and 
(B) high-fat diets.  Increased fat deposition in the liver was often visible while the liver 
was extracted from an anesthetized live animal. 
 
A 
 
B 
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Fig 9: Liver tissues were sliced and then stained with H&E, or Oil Red O.  Tissues slices 
were also subject to CARS microscopy to identify/confirm presence of fat droplets.  
Yellow arrows = nuclei stained with DAPI, Red Arrows = fat droplets. 
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                        Control        High fat                                       Control      High fat 
Fig 10: Blood chemistry a) Serum cholesterol levels, n= 10, p = 0.073, by t-test b) Serum 
triglyceride levels. n= 10, p = 0.103 , by t-test. Black bars are control rats and red bars 
indicate high fat rats.  
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                                 Control       High fat                                                      Control       High fat 
 
Fig 11:  Liver enzymes values in control and high fat rats a) Alanine transaminase. n=1 0, 
p= 0.226 by t-test  
b) Alkaline phosphatase levels. n= 10, p ≤ 0.001, Black bars are control rats and red bars 
are high fat rats. 
 
 
 
a b 
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                         Fig 12: Serum free fatty acid assay. n = 4, p =0.182(t-test). 
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Fig 13:  Lipid composition of liver tissue by Thin Layer Chromatography (TLC).  Liver 
tissues (50 mg) from 5 rats in each group were processed for lipid content and prepared 
for TLC.  Samples were spotted at the origins (arrows) and allowed to migrate up in a 
solvent (hexane, diethyl ether, acetic acid) saturated atmosphere.  Plates were then 
stained with iodine vapor. Control 1L11,1R12,2L13,2L16,2L18 and High fat 1LL, 2RO, 
P, 1LQ and 2LS are the names of the control and high fat rats analyzed. 
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Fig. 14:  Densitometry of TLC data. A) Triglyceride levels in liver. n=5, p=0.015 (t-test), 
b) Cholesteryl ester levels in liver . n= 5, p =0.007 Bands/spots of each control and HF 
groups were analyzed by ImageJ software and quantified.  
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Chapter 4 
Sinusoidal dysfunction in fatty liver disease 
4.1 Introduction 
 Sinusoidal endothelial dysfunction in the liver is marked by capillarization or 
defenestration, which is defined as the loss of fenestrae and the development of basement 
membrane (58). The LSEC dysfunction results in decreased endocytic capability (94). 
Recent studies reveal the involvement of LSEC dysfunction in NAFLD. Sinusoidal 
endothelial cells are subject to insulin resistance in fatty liver disease. It has also been 
observed that sinusoidal endothelial dysfunction precedes inflammation and fibrosis in 
fatty liver disease (40, 67, 95). Currently, there are no studies that elucidate the role of the 
endocytic function of the LSECs in fatty liver disease. 
  Hyaluronic acid (HA) is a matrix polysaccharide with repeated disaccharide units 
of D-glucuronic acid and N-acetylglucosamine. HA is a major constituent of the ECM, 
and serum HA is known to be associated with inflammation, wound healing, and 
regenerative morphogenesis. Elimination of denatured or excess HA from the circulation 
is necessary to maintain the normal range of blood viscosity (96). Though many studies 
show the elevation of serum HA in NAFLD, the reason behind the elevation has been 
unexplained.  
 In our current study, the liver tissues were subjected to scanning electron 
microscopy to reveal the structural changes in the fenestrae. The isolated hepatocytes and 
LSEC were stained with Oil Red O, BODIPY stains and CARS microscopy was 
performed to observe the lipid accumulation in the cells. Serum HA was measured in the 
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control and HFD rats. LSECs isolated from control and HFD livers were plated on 
fibronectin-coated wells and assayed for 
125
I-HA endocytosis.  RNA isolated from the 
LSEC of the control and HFD rats were analyzed by micro-array analysis to study the 
expression of different genes in the LSEC. 
4.2 Materials and methods 
4.2.1 SEM of the liver 
 The rat was anesthetized and the procedure detailed in chapter 2 was followed 
until after the cannulation of the liver with a catheter. The liver was then flushed with 
TBS and perfused with fixation buffer (3% glutaraldehyde, 2.5% paraformaldehyde, 
2mmol/L calcium chloride, 2% sucrose and 0.1 mol/L cacodylate buffer) at a constant 
perfusion rate of 10 mL/min for 10 minutes (97). The tissue is then isolated from the 
animal and cut into thin slices with a clean razor blade and stored in fixation buffer. The 
fixed tissues were then processed by the Microscopy Core Facility at UNL for scanning 
electron microscopy (SEM). 
4.2.2 Staining of cells 
 The isolation of the cells of the liver was performed as described in chapter 2. The 
isolated hepatocytes and sinusoidal endothelial cells were stained with Oil Red O and 
BODIPY. CARS imaging was performed to visualize the lipid content in the cells. Oil 
Red O staining was performed in the following manner. The isolated hepatocytes were 
cultured in DMEM with 8% FBS and sinusoidal endothelial cells were cultured in RPMI 
containing 0.5% BSA for at least one hour. Media was removed from cultured plates, 
plates were rinsed with 5 mL phosphate buffered saline (PBS), and the cells were fixed 
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with 5 mL 4% buffered formalin for 15 min at room temperature. After 10 min, the 
formalin was discarded and fresh formalin was added and incubated for at least 1 hr, 
followed by 2 rinses with sterile water and subsequent 5 min incubation with 60% 
isopropanol. The isopropanol was removed and the cells were stained for 10 min with 5 
ml of freshly diluted and filtered working Oil Red O solution (Working solution is 6 parts 
Oil Red O stock solution and 4 parts water). Oil red O stock solution is 0.35% oil red in 
100% isopropanol. The stain was then removed and the cells were washed 5 times with 
sterile water. Images of cells stained with Oil Red O were obtained with a phase contrast 
microscope (98, 99). 
 The fluorophore BODIPY specifically stains neutral lipids. BODIPY staining was 
performed following the procedure as described previously (100). The cells were cultured 
on fibronectin-coated plastic chamber slides. They were rinsed with Dulbecco’s 
phosphate buffered saline, fixed for 20 min with formaldehyde containing buffer (0.1 M 
PIPES pH 6.9, 1 mM EGTA, 3 mM MgSO4, 2.5% formaldehyde) and washed 3 times for 
10 min with D-PBS before a short permeabilization with D-PBS + 0.1% triton X-100. 
The cells were washed with D-PBS following permeabilization and BODIPY was added 
on to the coverslips and incubated for 30 min. A 1 mg/mL BODIPY stock solution 
dissolved in DMSO was then diluted to 0.1 mg/ml and added to the cells. The slides were 
washed three times with D-PBS for 10 min each. Finally, coverslips were mounted using 
the UltraCruz mounting media. The cells were then observed under a fluorescent 
microscope (100). 
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4.2.3 CARS imaging 
 The isolated hepatocytes and LSEC were cultured on fibronectin-coated chamber 
slides for two hours and then fixed with 4% buffered formalin. The cells were visualized 
using CARS imaging at 2845 cm
-1
 with the assistance of Mr.Xiangnan He under the 
direction of Dr. Yongfeng Lu, Professor of Electrical Engineering at the University of 
Nebraska.  
4.2.4 Measurement of serum Hyaluronate (HA) 
 The levels of HA in the serum from control and HFD rats were measured by 
ELISA using the Quantikine ELISA HA assay kit. The kit employs a solid phase ELISA 
to measure ≥ 35 kDa HA. It is a quantitative sandwich immunoassay method. The kit 
supplies a microplate onto which recombinant human (rh) Aggrecan, an HA binding 
protein has been pre-coated. Standards, controls, and samples were pipetted into the wells 
and any Hyaluronan present was bound by the immobilized rhAggrecan. After washing 
away any unbound substances, enzyme-linked rhAggrecan was added to the wells. It was 
followed by a wash to remove any unbound rhAggrecan-enzyme reagent and a substrate 
solution was added to the wells. The color development was stopped and measured. The 
intensity of color developed is in proportion to the amount of Hyaluronan bound in the 
initial step (Quantikine ELISA HA assay). 
4.2.5 In vitro endocytosis of
125
I-HA 
 The isolated sinusoidal endothelial cells were cultured on fibronectin-coated 12-
well plates in RPMI containing 0.05% BSA and allowed to recover for at least 90 min. 
Meanwhile two sets of endocytosis media (DMEM+0.05% BSA) containing 1) 1µg/ml 
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125
I-HA (hot) and 2) 1µg/mL 
125
I -HA+ 100 µg/mL unlabeled HA (hot +cold) was 
prepared. After the cells are recovered, RPMI media was aspirated and the media 
containing either hot or hot+cold HA was added to the cells. The internalization of 
hot+cold HA by the cells served as a control to measure the specificity of HA uptake. 
The cells were allowed to internalize 
125
I-HA for a period of 3 hours followed by three 
washes with HBSS (Hanks Buffered Salt Solution) and harvested using 0.5% NP-40. The 
radioactivity of the cell lysates was measured by gamma counter. The amount of 
radioactivity measured is proportional to the amount of 
125
I-HA taken up by the cells. The 
protein content of the lysates was measured using Coomassie blue Bradford protein assay 
and the amount of 
125
I- HA uptake is measured as CPM/mg protein (counts per 
minute/milligram protein).  
4.2.6 Western blot of the LSEC lysates 
 The cells were lysed with 0.5% NP-40 containing protease inhibitors such as 
EDTA and PMSF. The lysates were spun briefly to settle any cell debris and the protein 
concentrations were measured using Coomassie blue Bradford protein assay method. 
Equal amounts of protein from the lysates was loaded on a 5% acrylamide gel and 
transferred to a nitrocellulose membrane after SDS-PAGE. The membrane was probed 
with anti-rat Stabilin-2 (Ab30) antibody and detected with anti-mouse antibody 
conjugated to horse radish peroxidase.  
4.2.7 RNA isolation and microarray analysis  
 The isolated sinusoidal endothelial cells from replicates of control and HFD rats 
were stored in RNALater until utilized for RNA purification. RNA was isolated from the 
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replicates using the Trizol reagent (Life Technologies) followed by additional cleaning 
using an RNeasy kit (Qiagen). Microarray analysis was performed using Affymetrix Rat 
1.0 gene chips at the Center for Bioinformatics and Systems Biology, University of 
Nebraska Medical Center, Omaha. The microarray results were used to identify potential 
genes that are either up- or down-regulated in the high fat diet regimen.  
4.2.8 Analysis of Stab-2 gene expression by qPCR 
 RNA isolated from control and HFD rats were used for qPCR analysis of the 
difference in Stab-2 gene expression. Two different sets of primer pairs , 1)  Stab-2 2771 
For 5'-GAGGAAACGGGATTGACTGTGAACCCAT-3' and Stab-2 3590 rev 5'-
ATGCCGTTATGCAAGTCATTCTTCAGGAG-3' , 2) Stab-2 3343 For 5'-
TCTTTACCAAGTCTACTCACCCGTCTG-3' and Stab-2 Stab-2 3590 rev 5'-
ATGCCGTTATGCAAGTCATTCTTCAGGAG-3' were used. cDNA synthesis was 
performed using Revertaid first strand cDNA synthesis kit(Fermentas). qPCR was 
performed using iTaq Universal SYBR Green Supermix (Biorad). The samples were run 
on ABI 7500 (Applied Biosystems) on the standard protocol. GAPDH gene was used for  
the reference gene expression. The change in expression was calculated using the ΔΔCt 
method. 
4.3 Results 
 Staining of isolated hepatocytes from control and HFD rats showed considerable 
accumulation of fat in the hepatocytes in HFD rats as compared to the control (Fig 15). 
Staining of isolated sinusoidal endothelial cells reveals that these cells do not accumulate 
fats irrespective of the diet ingested (Fig 15). The scanning electron micrograph of the 
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liver tissue from the control and the HFD rats are not very different, though the 
fenestrations seems to be more disorganized in the HFD rats compared to the control (Fig 
16). Serum HA is elevated in the HFD rats (Fig 17). The in vitro endocytosis of I-HA 
experiments show that the uptake of  
125
I-HA is impaired in sinusoidal endothelial cells of 
the control rats compared to the HFD rats (Fig 18). The western blot of the lysates of the 
isolated LSEC culture of control and HFD rats show that the protein expression of Stab2 
remains the same in both control and HFD rats (Fig 19). Densitometry measurements 
show that the amount of protein expressed is not significantly different through the 
microarray data show a downward trend (Table 4). qPCR analysis of Stab2 gene 
expression shows that there is 42 % decrease in expression in HFD rat livers compared to 
the control rats (Fig 20). A preliminary list of the genes revealed by microarray analysis 
to be up-regulated or down-regulated by the high fat diet is given (Table 3 and table 4). 
Different inflammatory response genes such as IL-6, Ccr1, Orm1, Vnn1, Olr1 and Ccl12 
are upregulated, suggesting the role of stabilin-2 in inflammatory response to the high fat 
even before the fibrosis is set in. Other genes that are upregulated are Lbp, Ugt2b, Lox, 
Kng1, St8sia3, Lipc and LOC498793. Stabilin-1 and stabilin-2 are down regulated, but 
not to a significant level. qPCR analysis of the gene expression is required to give the 
exact fold change between the control and HFD rats. 
4.4 Discussion 
 NAFLD is the major predictor for more serious health problems such as metabolic 
syndrome, hepatitis and cirrhosis. The sedentary lifestyle, in addition with the increased 
consumption of refined foods rich in fats and fructose is likely the reason for the 
proliferation of this disorder.  It has been observed that a decrease in the consumption of 
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fatty refined foods and an increase in physical activity fully reverses NAFLD to normal 
healthy tissue (101). Though there are various studies that elucidate the effect of this 
metabolic disorder on the cells of the liver, the development of the disease is still very 
vague and requires more study. SEM of the liver reveals a change in the morphology of 
the fenestrae in the livers of the HFD rats. A decrease of the endocytic capability of the 
LSECs suggests that these cells are adversely affected during early stages of NAFLD. 
The staining of the isolated LSEC and hepatocyte helped identify that LSEC do not 
accumulate any fats suggesting that the direct effects of stored fatty acids (triglycerides) 
do not affect LSEC endocytosis directly, but that the effects of lipotoxicity may be in 
play.  
 The microarray results reveal certain genes of interest that are upregulated. 
Different inflammatory response genes such as IL-6, Ccr1, Orm1, Vnn1, Olr1 and Ccl12 
are upregulated, suggesting the role of LSEC in inflammatory response to the high fat 
even before the fibrosis is set in. IL-6 is an interleukin and the circulating levels and 
expression of IL-6 is often found elevated in fatty liver disease (102). Ccl12 is a 
chemokine and is similar to Ccl2 and it is usually elevated along with other cytokines in 
NAFLD (103). Orm1 encodes for alpha-1 acid glycoprotein, also known as orosomucoid 
1, whose expression is elevated as an acute immune response, has been observed to 
increase in hepatic steatosis (104).Vnn1 is an inflammatory response protein, which has 
been studied to be upregulated in fatty liver disease (105). Olr1 exhibits the activity of 
oxidized lipoprotein receptor, and is elevated as an inflammatory response. Though there 
is no literature pertaining to increased expression in NAFLD, Olr1 has been studied in 
relation to myocardial infarction (106). Other genes that are upregulated are Lbp, Ugt2b, 
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Lox, Kng1, St8sia3 and Lipc. Ugt2b belongs to the family of UDP-glucoronyl 
transferases, a group of enzymes involved in glucoronidation of toxic substances and aids 
in their removal.  Drug metabolic alterations have been observed in NAFLD (107) and a 
study of the elevation of Ugt2b gene will provide a deeper understanding of the process 
in NAFLD. Lbp is lipopolysaccharide-binding protein and is found to be elevated in 
response to circulating endotoxin (108). Lox is lysyl oxidase and has been studied for its 
role in collagen fibril formation and fibrogenesis (109) and is being implicated as one of 
the genes in fatty liver disease in relation to fibrogenesis (110). Kng1 has been implicated 
in a positive role for endothelial cell proliferation and has been found to be one of the 
genes routinely over expressed in NAFLD (111). St8sia3 encodes for a protein involved 
in glycosphingolipid pathway and protein glycosylation (112). The relation between over 
expression of this gene and NAFLD has not yet been studied.  Lipc encodes hepatic 
triglyceride lipase and has been studied in association with diabetes mellitus (113), but no 
relevant studies in relation to NAFLD have been carried out. Scd1 encodes for stearoyl-
coA desaturase, which is a key enzymes in the synthesis of unsaturated fatty acid chains. 
There are various studies reporting the increase in expression of Scd1 in the livers in fatty 
liver disease (114-116), though we have observed that the expression of Scd1 is down 
regulated in LSEC. An in-depth analysis of genes in other lipid metabolic pathways is 
required to understand the downward trend in expression of Scd1 observed in LSEC. We 
observed that expression of stabilin-1 and stabilin-2 are down-regulated as seen by 
microarray analysis, and stab2 gene expression is decreased by 42 % as validated by 
qPCR. 
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 Elevated serum HA levels are in agreement with the decreased LSEC endocytosis 
rate, while receptor levels are unchanged indicating that endocytic machinery for receptor 
internalization may be impaired.    These studies along with the investigation of what 
LSEC genes are affected by the high fat diet open avenues for understanding the role of 
LSEC in early events of NAFLD. 
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Fig 15:  Isolated hepatocytes and LSEC as viewed by either BODIPY staining, Oil Red O 
staining, or Coherent Anti-Stokes Raman Scattering (CARS) Microscopy.  BODIPY 
stains fat droplets in the fluorescent green wavelength (Ex 495:Em 519), Oil Red O stains 
fat droplets red under PC light microscopy, and CARS microscopy at 2845 cm
-1
 for CH2 
symmetric stretching vibration.  Yellow arrow shows distinction of a single hepatocyte in 
a large group of LSEC stained with Oil Red O.  SEC do NOT store fats 
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Fig 16: SEM micrographs of livers from rats fed control (A-D) and HF diets (E-H). 
Fenestration (yellow arrows) in the LSEC of both groups is in good condition although a 
little more disorganized in the HF group. The green arrows point to adjacent hepatocytes 
between the sinusoidal vessels and the red arrows show fat droplets that originated in the 
hepatocytes. The spherical shapes in G and H are displaced lipid droplets. 
 
54 
 
 
                   
Fig 17: Serum HA levels were measured from both control and HFD rats using the 
Quantikine ELISA HA assay kit (R &D systems). Each data point represents an animal 
with the red bars indicating the mean, n=9, p = 0.02 by t-test. 
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Fig 18: In vitro endocytosis; LSEC isolated from control and HFD livers were plated on 
fibronectin-coated plate, recovered for 2 hours and then allowed to internalize 
125
I-HA for 
3 hours. Cells were then washed and measured for radioactivity and protein levels. n=4, 
p= 0.018, by t-test. 
 
 
                       
                       Control rats       High fat rats 
 Fig 19: Western blot of LSEC lysates from control and HFD rats. The proteins were 
probed with Stabilin-2 antibody (Ab30).  The two arrows correspond to the two isoforms 
of stabilin-2 protein (300 and 170 kd).  The black boxes indicate the marker of 250 kd. 
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Table 4 Summary list of genes upregulated  
Gene High fat 
/Control 
Function 
IL-6 1.86 Interleukin 
Ccr1 1.79 Chemokine receptor 
Orm1 2.7 Orosomucoid 1 
Vnn1 2.1 Vanin 1 
Olr1 1.99 Oxidative low density lipoprotein receptor 1 
Ccl12 2.03 Cytokine 
Lbp 2.17 Lipopolysachcharide binding protein 
Ugt2b 2.84 UDP-glucoronyl transferase family 
Lox 2.83 Lysyl oxidase 
Kng1 2.56 Kininogen 1 
St8sia3 2.27 alpha2-8 sialyltransferase. 
Lipc 1.93 Hepatic lipase 
 
Table 5 Summary list of genes down regulated 
Gene High fat/Control  Function 
Scd1 0.3 Stearoyl CoA desaturase. 
Stabilin-1 0.65 Scavenger receptor 
Stabilin-2 0.66 Scavenger receptor 
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                                                 Control              High fat  
              Fig 20: qPCR analysis of Stab-2 gene expression. n= 3, p≤ 0.001(t-test).  
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Chapter 5  
Conclusions and Future Directions 
 The pathogenesis of NAFLD is not yet clear and there is an on-going search for 
specific serum markers that help diagnose NAFLD. Though there are various research 
studies to elucidate the effect of fatty liver on the different cells of the liver, sufficient 
research into the role of liver sinusoidal endothelial cells (LSEC) in the pathogenesis of 
the disease has not been done. The LSEC act as a liver sieve by allowing macromolecules 
and chylomicrons to traverse through their fenestrations (sieve plates) to hepatocytes 
(58). Since LSEC regulate serum-derived macromolecular exposure to hepatocytes, we 
asked what role LSECs play in the pathogenesis of NAFLD. Two sets of rats were 
maintained on standard and high fat diets (HFD) respectively for a period of 8 weeks. 
The lipid accumulation in the rat livers, isolated hepatocytes and LSEC were visualized 
by Oil Red O, BODIPY and CARS imaging. These analyses reveal the accumulation of 
lipid droplets in the hepatocytes of HFD fed rats in contrast to the LSECs. These studies 
reveal that the LSEC do not accumulate fat due to the high fat diet and do not respond to 
the diet in a similar fashion as the hepatocytes. We carried out in vitro endocytosis of 
125
I-HA that showed 
125
I-HA uptake is significantly higher in isolated SEC of control rats 
compared to HFD fed rats, as measured by statistical analyses using t-test. We also 
observed that serum hyaluronate (HA) levels and alkaline phosphatase (ALP) levels were 
increased in HFD fed rats, in contrast to alanine transaminase (ALT), triglycerides and 
cholesterol, which remained the same. Though the fasting serum triglyceride levels of the 
HFD were not significantly different from the control rats, thin layer chromatography of 
the lipid extracts of the liver tissues from the HFD and control rats showed a significantly 
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higher amount of triglycerides and cholesteryl ester in the HFD rats compared to the 
control rats, as measured by statistical analyses using t-test. All these experiments 
established that the rats fed on HFD were suffering from fatty liver disease after 8 weeks 
of high fat food consumption. 
    The most significant observation of the study so far has been the decreased 
uptake of hyaluronate (HA) by the isolated SEC. Serum HA is also significantly high in 
the HFD rats compared to the control. Serum HA has also been observed to be elevated 
in various diseased conditions including diabetes mellitus (117), liver hepatitis  and 
cirrhosis (118) and hepato-cellular carcinoma  (119), but the reason for the elevated 
serum HA in these conditions  has not been elucidated.  
 The Stabilin-2 receptor is the only receptor on the SEC that is responsible for the 
clearance of HA (26) and other matrix material. The decrease in uptake of HA in the 
livers of HFD rats suggests the impairment of protein function, which could be either due 
to the decreased production of the protein, the decreased expression of the stabilin-2 gene 
or a malfunction in the endocytic pathway. The Stabilin-2 protein expression was 
measured by performing a western blot using the isolated LSEC culture lysates. The 
study revealed that there is no difference in the protein expression between the control 
and HFD rats. RNA was isolated from the LSECs of the control and HFD rats and 
subjected to microarray analysis, which revealed that the stabilin-2 gene expression was 
not changed between the control and HFD rats. Post-translational modification of 
stabilin-2 might be a reason for its decreased endocytic capability in the HFD fed rats.  
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  Insulin resistance plays a role in the pathogenesis of liver damage in fatty liver 
disease (120). Some studies also suggest that both of them have a common pathogenic 
mechanism (121). Insulin resistance and hyper glycemic conditions results in activation 
of four pathways, the Protein Kinase C/Diacyl Glycerol pathway (PKC/DAG), the 
sorbitol pathway, the hexosamine pathway and the formation of advanced glycation end 
products (AGE) (122). The hexosamine pathway results in the channeling of fructose-6-
phosphate to GlcNAC (N-Acetyl glucosamine). The increased production of GlcNAC 
results in post translation attachment of O-GlcNAC to serine and threonine residues of 
proteins, resulting in their inactivation (123). As there is an evidence that serine-2497 on 
the cytoplasmic side of the Stab-2 protein is phosphorylated and activated by 
phosphorylation (unpublished data), it will be interesting to see if the protein undergoes 
post translational O-GlcNAC attachment due to hyperglycemia and insulin resistance.   
 Insulin promotes nitric oxide (NO) production through the activation of the 
PI3K/Akt/endothelial nitric oxide synthase (eNOS) signaling pathway. The 
phosphorylation of eNOS at Serine 1179 results in vasodilatation and vascular protection. 
When insulin resistance develops, the PI3K pathway is inhibited and the PKC/DAG 
pathway is initiated. The PKC/DAG pathway is known to decrease eNOS activity (124). 
Hyperglycemia also results in mitochondrial dysfunction, which results in increased 
superoxide production (125). The superoxides result in the production of reactive 
peroxynitrite species which uncouple and inactivate eNOS by binding to 
tetrahydrobiopterin which is an essential cofactor for eNOS activity, resulting in 
production of more reactive species instead of NO (126). Hepatocytes have been shown 
to increase the production of inducible nitric oxide synthase (iNOS) as an inflammatory 
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response due to high fat diet. iNOS is known to cause insulin resistance by S-
nitrosylation of the insulin signaling proteins (126).  
 The response of the LSEC to hyperglycemic conditions is still being studied.  
LSEC undergo insulin resistance due to hyperglycemic conditions in fatty liver disease 
and it precedes fibrosis and inflammation. This study is based on the decrease of Akt 
phosphorylation and eNOS in the liver, in vivo hemodynamic studies and decrease in 
vasodilatation (95). Another study by the same group suggests that iNOS production is 
increased in the hepatocytes due to high fat diet, which induces insulin resistance in 
sinusoidal endothelial cells, measured by in situ liver perfusion and hemodynamic 
studies. It is not clear how isolated LSECs respond (67). In steatosis, it has also been 
observed that the sinusoidal narrowing takes place and there is a decrease in sinusoidal 
flow (127). In situ assessment reveals an increase in portal pressure and intra hepatic 
resistance due to impaired sinusoidal endothelial function. An increase in 
vasoconstrictors and morphological disorganization was observed which precedes 
inflammation and fibrosis (128).  
 It will be beneficial to study the effect of insulin on the isolated LSEC, by 
exposing it to insulin and performing a pathway array analysis to study which proteins 
are being activated/deactivated due to insulin exposure in both control and HFD rat 
LSEC. The study of the changes in gene expression in the proteins in the insulin signaling 
pathway by qPCR will reveal the changes in the gene expression in the cells due to 
hyperglycemia and insulin resistance. Potential candidate genes are the class of  Insulin 
receptors, eNOS, O-GlcNAC transferase, and inflammatory cytokines such as IL-6, TNF 
and TGF-β. The effect of insulin resistance needs to be observed in isolated LSEC, 
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paying special attention to the hexosamine pathway and the production of O-GlcNAC.  
Mass spectrometric studies of the Stabilin-2 protein will reveal if there is a post 
translation attachment of O-GlcNAC due to insulin resistance. 
 The liver sinusoidal endothelium undergoes changes in its unique phenotype and 
undergoes the process known as capillarization, which is the loss of LSEC fenestration 
and development of basement membrane (56). Capillarization has been known to occur 
in NAFLD and seen to precede onset of fibrosis (129). LSEC fenestrae are maintained by 
VEGF production by hepatocytes and consequent activation of eNOS by the endothelial 
cells (130). It has been observed in a previous study that LSEC differentiation plays a 
role in the fibrogenesis. LSEC differentiation promotes quiescence of hepatic stellate 
cells (HSC) and thereby promotes regression and inhibits progression of liver fibrosis 
(57). It has also been observed that the endocytic activity of the LSEC is reduced due to 
capillarization (59). All the above observations can be used to draw the following 
hypothesis that high fat diet causes the hepatocytes to produce more iNOS that cause 
insulin resistance in the endothelial cells and subsequent dysfunction.  
 The insulin resistance in the LSECs causes it to decrease the eNOS activity, 
which causes capillarization. The loss of the phenotype of the LSEC results in the 
activation of stellate cells and the fibrogenesis of the liver. The insulin resistance might 
also cause the O-GlcNAC addition on the stabilin-2 receptors that lose their ability to 
clear HA and other molecules. An insight into the HA secretion and degradation is 
necessary to establish the link between the increase in serum HA in liver damage and 
sinusoidal endothelial dysfunction. 
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 Alkaline phosphatase is one of the liver enzymes studied to diagnose liver disease 
condition, the other two being the aspartate and alanine aminotransferases. Alkaline 
phosphatase is elevated in conditions of hepato-cellular damage and biliary obstruction. 
The expression of this enzyme is increased slightly in hepato-cellular damage, and 
induced to elevated levels and made into soluble forms especially when the bile ducts are 
obstructed (131). This could suggest a possible mechanism where the ductules are 
affected. It has also been observed that the alkaline phosphatase levels are increased in 
fatty liver disease even though there is no significant increase in triglyceride levels in the 
serum, (132). Our experiments also revealed similar observations. Even though rats do 
not have a gall bladder, bile is produced by the hepatocytes and secreted into bile ducts 
(92). It has also been observed that biliary obstruction results in decreased endocytic 
activity in hepatocytes and sinusoidal endothelial cells (93).  An investigation between 
the sinusoidal endothelial dysfunction and the biliary obstruction is required. 
 Advanced glycation endproducts (AGE) products are seen to be elevated in 
NAFLD (133). The Stab-2 receptor is also involved in the removal of AGE products, as 
mentioned previously (29). It is not yet known if the isolated LSECs from HFD rats have 
a difference in their ability to remove AGE products, compared to the control diet rats. It 
has also been observed that the pre-exposure of the sinusoidal endothelial cells to AGE 
can result in decreased endocytic ability of the cells (134). The relation between elevated 
AGE and sinusoidal endothelial dysfunction in NAFLD has not yet been explored. 
 Chronic kidney failure is often associated with NAFLD (135). Deficiency of the 
Stabilin receptors in the liver results in glomerular nephritis of the kidney due to ECM 
buildup in the glomeruli (136). The link between NAFLD and chronic kidney failure 
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because of sinusoidal endothelial dysfunction is not yet known. As the study of the 
pathogenesis of NAFLD is a vast field, with new research observations coming in with 
each study, the above suggestions will provide a preliminary understanding of the role of 
LSEC in the pathogenesis of NAFLD. There are still many unknown molecular events in 
the initial stages of NAFLD development and pathogenesis. 
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